1 Introduction Fetal arrhythmias occur in about 1% of pregnancies and sotalol, a beta-blocker, is one of the proposed first choice therapeutic options [1, 2]. The variety of sotalol dosing regimens for fetal tachycardia is based on scarce evidence. Only a few studies have been performed, with relatively small numbers of participants, but all studies show that only part of the group receiving sotalol is responsive to the therapy [3-6].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Anne
Contact Anne, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack